reported in patients with prolactinomas27-32 after testing with thyrotrophin-releasing hormone and dopamine antagonists. More reliable information seems likely to come from investigation of the effect on the normal tissue surrounding the adenoma of the increased dopaminergic activity that results from the prolactin feedback on the hypothalamus. Preliminary studies on the gonadotrophin response to metoclopramide27 and the thyrotrophin response to domperidone28 in patients with prolactinomas provide evidence for this hypothesis. If substantiated, this may lead to earlier reliable detection of microadenomas, with prospects of even better "cure" rates. 1 Hwang P, Guyda H, Friesen H. A radioimmunoassay for human prolactin.
1 Gross CE, Binet EF, Esguerra JV. Metrizamide cisternography in the evaluation of pituitary adenomas and the empty sella syndrome.
J' Neurosurg 1979; 50:472-6. In fatal cases the lungs bear the brunt of the disease. The usual picture is an extensive confluent bronchopneumonia, which sometimes spreads so much as to have a lobar distribution. When the pneumonia is lobular and closely associated with the bronchioles, the organism may be presumed to have gained entry to the lungs by inhalation. When, on the other hand, the distribution of the pneumonia is fully lobar, the possibility of blood-borne dissemination should also be considered. In classic pneumococcal lobar pneumonia the rapid spread of infection is taken as evidence of an allergic phenomenon superimposed on the infective element: a whole lobe is rapidly submerged in a gigantic wave of oedematous exudate. This phenomenon has been explained on the relatively symptomless passage ofthe pneumococci through the lungs after their initial inhalation, their direct passage into the blood stream, their proliferation in the cells of the reticuloendothelial system, and their return to the blood to be carried once more to the lungs as part of a septicaemia. As they return to the now sensitised lungs so they evoke a massive allergic response that implicates an entire lobe.
Hernandez and colleagues4 have recently reviewed the necropsy findings in 20 cases of legionnaires' disease. The constant features were limited to the lungs. Usually there was a confluent bronchopneumonia, but sometimes the consolidation had a lobar distribution. In the 17 patients who died in the acute phase the characteristic histological features were an extensive exudation into the alveoli of macrophages and neutrophil polymorphs in varying proportions with an admixture of red cells and fibrin. The inflammatory cells frequently showed lysis, and typically there were areas of coagulative necrosis of the parenchyma of the lung and oedematous thickening of the septa of the alveoli. In the three patients who died after clinical resolution of the acute process, there was an organised pneumonia; the exudate in the alveoli had undergone conversion into granulation tissue with focal obliteration of the septal framework of the alveoli. In one case the organisation had proceeded to diffuse fibrosis. By contrast, there were few noteworthy findings in the other organs: one instance of non-bacterial thrombotic endocarditis of the marantic type and two of haemorrhagic infarction of the adrenal glands. Nine of the patients had had underlying disorders for which immunosuppressive treatment had been given, and all 20 cases had serious diseases in addition to legionnaires' disease. Their ages ranged from 43 to 86 years.
The overall picture in the lungs is one ofextensive, confluent, bilateral bronchopneumonia which is associated with the bronchioles even when a whole lobe is implicated. The pathogenesis of legionnaires' disease does not therefore seem to parallel pneumococcal lobar pneumonia. On the other hand, the microscopical features in the two diseases are closely similar, with two exceptions: the coagulative necrosis of the lung parenchyma and the oedema of the alveolar septa seen in legionnaires' disease. There is no suppurative destruction of the bronchial system, such as is found in pyococcal bronchopneumonia, nor is there the interstitial inflammatory cellular infiltration seen in viral and rickettsial pneumonias. In all, the morbid anatomy of legionnaires' disease appears to be distinctive-though the diagnosis must always be confirmed by bacteriological and serological studies. On 
Hyperlipidaemia advances and retreats
The suggestion that hyperlipidaemia, and especially raised serum cholesterol concentrations, is an important correlate of ischaemic heart disease has led to repeated attempts to lower serum lipid concentrations and so to prevent the disease. The results of such attempts have been mixed. The Coronary Drug Project' established that two drugs studied (D-thyroxine and oestrogens) were dangerous, another (nicotinic acid) was unpalatable, and a further agent (clofibrate) unacceptably often caused gall-bladder disease2: none prevented recurrent heart disease. The results of the WHO clofibrate trial3 showed that primary drug prevention of ischaemic heart disease was feasible. Nevertheless, anoverall increased mortality outweighed the benefit for the persons studied, who were not especially at risk of heart disease. benefit, and the main positive finding was a surprisingly high incidence of aspirin-related side effects.
An important contribution was a report from the Minnesota Programme on Surgical Control of the Hyperlipidaemias. This is a careful prospective study of exclusion of one-third of the ileum in hypercholesterolaemia: patients and controls will be followed up for five years with sequential coronary arteriograms. When the results are available there will be answers to the important questions of whether atheroma regresses and whether coronary morbidity and mortality are reduced. This is the first adequate study of surgery in hypercholesterolaemia.
The interaction of systemic and biliary lipid metabolism was reviewed in detail by various speakers. Clofibrate and, to a less extent, nicotinic acid induce oversaturation of bile with cholesterol5 and cause gall stones2 3: analogues of these drugs might carry a lesser risk, but that remains only a speculation. Analysis of bile had shown that cholestyramine and probucol should be free of this problem, and chenodeoxycholic acid should actually protect against gall stones while reducing hypertriglyceridaemia.
A bewildering number of dietary modifications (20) and drugs (64, including 18 analogues of clofibrate and nicotinic acid) were discussed at the meeting. Three deserve particular
